Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of California, San Francisco
Memorial Sloan Kettering Cancer Center
Centre Oscar Lambret
Centre Oscar Lambret
Massachusetts General Hospital
The Netherlands Cancer Institute
Wake Forest University Health Sciences
Full-Life Technologies GmbH
Memorial Sloan Kettering Cancer Center
Washington University School of Medicine
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
University of California, San Francisco
Washington University School of Medicine
Memorial Sloan Kettering Cancer Center
Assistance Publique Hopitaux De Marseille
Washington University School of Medicine
Lyndra Inc.
Invectys
Memorial Sloan Kettering Cancer Center
Ohio State University Comprehensive Cancer Center
Washington University School of Medicine
Assistance Publique Hopitaux De Marseille
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Universitair Ziekenhuis Brussel
Merck Sharp & Dohme LLC